Cabot Toekomstige groei
Future criteriumcontroles 3/6
Cabot zal naar verwachting groeien in winst en omzet met respectievelijk 18.9% en 3.4% per jaar. De winst per aandeel zal naar verwachting groeien met 20.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 21.2% zijn.
Belangrijke informatie
18.9%
Groei van de winst
20.45%
Groei van de winst per aandeel
| Chemicals winstgroei | 16.5% |
| Inkomstengroei | 3.4% |
| Toekomstig rendement op eigen vermogen | 21.22% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 06 Jul 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • Jun 26
CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook
Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
Nieuw narratief • Jun 23
Battery And Data Center Demand Will Drive Long-Term Upside Potential
Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Jun 22
Cabot: Battery Materials Business Growing On Gigafactory & Data-Centre Demand
Summary Cabot Corporation has demonstrated unexpected resilience, with shares up nearly 40% year-to-date and technical momentum signaling further upside potential. Upgrading CBT to 'Hold' as strong buying volume and a bullish MACD crossover suggest a possible golden cross, pending confirmation. Battery Materials led Q2 with 43% top-line growth, driving Performance Chemicals operating profit close to $60 million and fueling positive EPS revisions. Despite margin pressure in Reinforcement Materials, management guides for sequential EBIT improvement, while mission-critical products underpin long-term demand. Read the full article on Seeking AlphaAnalyse-artikel • Jun 21
Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating
Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...Nieuw narratief • Jun 09
Battery And Data Center Demand Will Support A Steady Long Term Materials Story
Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?Analyse-artikel • Nov 03
Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?
While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...Analyse-artikel • Sep 11
Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch
With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...Analyse-artikel • Jul 20
Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?
Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...Analyse-artikel • Jun 23
Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Analyse-artikel • Apr 25
These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Apr 10
Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price
Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...Analyse-artikel • Mar 12
A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price
Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...Seeking Alpha • Feb 13
Cabot Corporation: Reinforcing Positive Shareholder Value
Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking AlphaSeeking Alpha • Jan 30
Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)
Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking AlphaAnalyse-artikel • Jan 29
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...Analyse-artikel • Jan 15
Is Cabot (NYSE:CBT) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Jan 02
Returns On Capital Are A Standout For Cabot (NYSE:CBT)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analyse-artikel • Dec 06
Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...Seeking Alpha • Nov 14
Cabot: Less Than 5% Annualized Upside
Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking AlphaAnalyse-artikel • Oct 31
Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analyse-artikel • Oct 19
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...Analyse-artikel • Oct 07
Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Analyse-artikel • Sep 25
Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...Analyse-artikel • Aug 19
Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)
Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...Seeking Alpha • Jul 31
Cabot Corporation: Now A 'Hold' (Rating Downgrade)
Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking AlphaAnalyse-artikel • Jul 18
Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43
Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 9/30/2028 | 3,871 | N/A | 271 | 561 | 5 |
| 9/30/2027 | 3,745 | 371 | 268 | 533 | 6 |
| 9/30/2026 | 3,624 | 308 | 200 | 454 | 6 |
| 3/31/2026 | 3,575 | 281 | 432 | 671 | N/A |
| 12/31/2025 | 3,607 | 306 | 401 | 667 | N/A |
| 9/30/2025 | 3,713 | 326 | 364 | 665 | N/A |
| 6/30/2025 | 3,815 | 418 | 321 | 650 | N/A |
| 3/31/2025 | 3,908 | 426 | 288 | 608 | N/A |
| 12/31/2024 | 3,991 | 417 | 420 | 711 | N/A |
| 9/30/2024 | 3,994 | 374 | 451 | 692 | N/A |
| 6/30/2024 | 3,958 | 470 | 399 | 626 | N/A |
| 3/31/2024 | 3,910 | 443 | 407 | 662 | N/A |
| 12/31/2023 | 3,924 | 433 | 385 | 648 | N/A |
| 9/30/2023 | 3,931 | 437 | 351 | 595 | N/A |
| 6/30/2023 | 4,078 | 300 | 306 | 562 | N/A |
| 3/31/2023 | 4,259 | 315 | 127 | 353 | N/A |
| 12/31/2022 | 4,318 | 348 | -15 | 201 | N/A |
| 9/30/2022 | 4,321 | 206 | -111 | 100 | N/A |
| 6/30/2022 | 4,113 | 142 | -106 | 95 | N/A |
| 3/31/2022 | 3,881 | 130 | -65 | 132 | N/A |
| 12/31/2021 | 3,631 | 98 | -9 | 187 | N/A |
| 9/30/2021 | 3,409 | 247 | 62 | 257 | N/A |
| 6/30/2021 | 3,164 | -54 | 103 | 256 | N/A |
| 3/31/2021 | 2,765 | -144 | 184 | 334 | N/A |
| 12/31/2020 | 2,633 | -219 | 132 | 293 | N/A |
| 9/30/2020 | 2,614 | -238 | 177 | 377 | N/A |
| 6/30/2020 | 2,782 | 65 | 244 | 475 | N/A |
| 3/31/2020 | 3,109 | 103 | 195 | 441 | N/A |
| 12/31/2019 | 3,243 | 127 | N/A | 507 | N/A |
| 9/30/2019 | 3,337 | 155 | N/A | 363 | N/A |
| 6/30/2019 | 3,360 | 217 | N/A | 321 | N/A |
| 3/31/2019 | 3,369 | 273 | N/A | 268 | N/A |
| 12/31/2018 | 3,343 | 77 | N/A | 214 | N/A |
| 9/30/2018 | 3,242 | -114 | N/A | 298 | N/A |
| 6/30/2018 | 3,115 | -136 | N/A | 300 | N/A |
| 3/31/2018 | 2,966 | -177 | N/A | 371 | N/A |
| 12/31/2017 | 2,826 | 69 | N/A | 286 | N/A |
| 9/30/2017 | 2,717 | 246 | N/A | 348 | N/A |
| 6/30/2017 | 2,613 | 225 | N/A | 288 | N/A |
| 3/31/2017 | 2,529 | 234 | N/A | 262 | N/A |
| 12/31/2016 | 2,419 | 209 | N/A | 416 | N/A |
| 9/30/2016 | 2,411 | 145 | N/A | 392 | N/A |
| 6/30/2016 | 2,463 | 136 | N/A | 516 | N/A |
| 3/31/2016 | 2,536 | -366 | N/A | 482 | N/A |
| 12/31/2015 | 2,662 | -388 | N/A | 526 | N/A |
| 9/30/2015 | 2,871 | -336 | N/A | 499 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei CBT ( 18.9% per jaar) ligt boven de spaarquote ( 3.5% ).
Winst versus markt: De winst van CBT ( 18.9% per jaar) zal naar verwachting sneller groeien dan de US markt ( 18% per jaar).
Hoge groeiwinsten: De winst van CBT zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van CBT ( 3.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 12.7% per jaar).
Hoge groei-inkomsten: De omzet van CBT ( 3.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen CBT zal naar verwachting over 3 jaar hoog zijn ( 21.2 %)
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/07/14 21:12 |
| Aandelenkoers aan het einde van de dag | 2026/07/14 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/09/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Cabot Corporation wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Benjamin Kallo | Baird |
| Michael Leithead | Barclays |
| David Begleiter | Deutsche Bank |